Biosimilars Learning Library
Biosimilars have been transforming oncology treatment, by offering additional treatment possibilities and improving access to medication for patients. Explore ONS resources and additional resources including practice tools, courses, case studies, and more in this learning library.
Courses
Case Studies
The below case studies will include an interactive platform to assist oncology nurses in their conversations with patients. The clinical scenario will review commonly asked patient questions and concerns about biosimilars and their use in oncology practice.
Produced by ONS, with financial support from Pfizer Inc., a member of the ONS Corporate Council.
Practice Tools
Focus on Biosimilars: Oncology Nurses Identify Knowledge Gaps and Brainstorm Concepts for Education
ONS Biosimilars FAQs and Terminology Resource Sheet
Produced by ONS, with financial support from Pfizer Inc., a member of the ONS Corporate Council.
ONS Articles
Clinical Journal of Oncology Nursing Articles
Clinical Trials: Nursing Roles During the Approval Process and Pharmacovigilance of Biosimilars
Biosimilars: Exploring the History, Science, and Progress
Approval Process: An Overview of Biosimilars in the Oncology Setting
ONS Voice Articles
FDA Publishes Three New Biosimilars Resources for Healthcare Providers
An Oncology Nursing Overview of Biosimilars
Biosimilars and Gene Therapy Are Making Great Strides in Cancer Care
Nurses Will Forge New Territory With Biosimilars in Cancer Care
Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care
An Oncology Nursing Overview of Biosimilars
Trastuzumab Biosimilar Has Comparative Safety and Efficacy After Long-Term Follow-Up
Health Policy Advances Cancer Treatment Options in the Era of Biosimilars
Biosimilars and Oral Agents Lead New Approvals in the Cancer Setting